Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
The Journal of Cell Biology
|
June 13, 1998
Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions
M Yáñez-Mó, A Alfranca, C Cabañas, et al.
Pituitary
|
November 11, 2015
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
I Bernabeu, A Pico, E Venegas, et al.
Pituitary
|
May 6, 2016
Erratum to: Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
I Bernabeu, A Pico, E Venegas, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 20, 2001
CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells
M A García-López, F Sánchez-Madrid, J M Rodríguez-Frade, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2016
Validation of PHPQoL, a Disease-Specific Quality-of-Life Questionnaire for Patients With Primary Hyperparathyroidism
Susan M Webb, M Puig-Domingo, C Villabona, et al.
The Journal of Biological Chemistry
|
April 11, 2001
BENE, a novel raft-associated protein of the MAL proteolipid family, interacts with caveolin-1 in human endothelial-like ECV304 cells
M C de Marco, L Kremer, J P Albar, et al.
Clinical and Experimental Immunology
|
October 1, 1996
Expression of functionally active alpha 4 beta 1 integrin by thymic epithelial cells
M Nieto, M Gómez, P Sánchez-Mateos, et al.
Journal of Endocrinological Investigation
|
March 8, 2021
Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas
M Araujo-Castro, C Robles Lázaro, P Parra Ramírez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 12, 2010
Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study
M Marazuela, A E Paniagua, M D Gahete, et al.
Journal of Endocrinological Investigation
|
January 6, 2024
Quantitative analysis of Tr1 lymphocytes in patients with type 2 diabetes mellitus
C Knott-Torcal, N S de la Blanca, A Serrano-Somavilla, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
The Journal of Cell Biology
|
June 13, 1998
Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions
M Yáñez-Mó, A Alfranca, C Cabañas, et al.
Pituitary
|
November 11, 2015
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
I Bernabeu, A Pico, E Venegas, et al.
Pituitary
|
May 6, 2016
Erratum to: Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
I Bernabeu, A Pico, E Venegas, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 20, 2001
CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells
M A García-López, F Sánchez-Madrid, J M Rodríguez-Frade, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2016
Validation of PHPQoL, a Disease-Specific Quality-of-Life Questionnaire for Patients With Primary Hyperparathyroidism
Susan M Webb, M Puig-Domingo, C Villabona, et al.
The Journal of Biological Chemistry
|
April 11, 2001
BENE, a novel raft-associated protein of the MAL proteolipid family, interacts with caveolin-1 in human endothelial-like ECV304 cells
M C de Marco, L Kremer, J P Albar, et al.
Clinical and Experimental Immunology
|
October 1, 1996
Expression of functionally active alpha 4 beta 1 integrin by thymic epithelial cells
M Nieto, M Gómez, P Sánchez-Mateos, et al.
Journal of Endocrinological Investigation
|
March 8, 2021
Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas
M Araujo-Castro, C Robles Lázaro, P Parra Ramírez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 12, 2010
Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study
M Marazuela, A E Paniagua, M D Gahete, et al.
Journal of Endocrinological Investigation
|
January 6, 2024
Quantitative analysis of Tr1 lymphocytes in patients with type 2 diabetes mellitus
C Knott-Torcal, N S de la Blanca, A Serrano-Somavilla, et al.
Page
of 7